Seed Grants to Support Opioid Research Announced

UNIVERSITY PARK, Pa. — Penn State’s Social Science Research Institute (SSRI), in collaboration with the Clinical and Translational Science Institute (CTSI) has awarded over $200,000 in funding to support 10 new interdisciplinary teams of Penn State researchers whose work is aimed at combating the opioid epidemic.
Published: Sep 26, 2018

“These teams are developing novel translational research programs to advance solutions to the opioid crisis, from discovery-oriented research to dissemination and implementation science,” said Susan McHale, SSRI director and associate director of the CTSI.

The funded projects and research teams are:

— "'Alexa, I’m in pain!' A Real-Time Mindfulness Intervention to Control Pain: Delivery Through a Conversational Agent" — Saeed Abdullah, College of Information Sciences and Technology; Stephanie Lanza, College of Health and Human Development; Sebrina Doyle, College of Health and Human Development; Robert Roeser, College of Health and Human Development; and David Almeida, College of Health and Human Development.

— "Predicting spatial-temporal patterns of opioid use with criminal and overdose data in Pennsylvania" — Qiushi Chen, College of Engineering; Conrad S. Tucker, College of Engineering; Glenn Sterner, Penn State Abington; and Joel Segel, College of Health and Human Development.

— "Using Integrated Databases to Examine Patient Outcomes in Children with a History of Neonatal Abstinence Syndrome" — Tammy Corr, College of Medicine; Max Crowley, College of Health and Human Development; Douglas L. Leslie, College of Medicine; Jeffrey R. Kaiser, College of Medicine; Paul L. Morgan, College of Education; and Guodong Liu, College of Medicine.

— "Opioid Prescription Practices and Risk Factors for Persistent Use After Childbirth" — Danielle Downs, College of Health and Human Development; Lisa Bailey-Davis, Geisinger Commonwealth School of Medicine; Tammy Corr, College of Medicine; Timothy Deimling, College of Medicine; Richard Legro, College of Medicine; Dhanya Mackeen, Geisinger Commonwealth School of Medicine; Jaimey Pauli, College of Medicine; and Mark Stephens, College of Medicine.

— "Perinatal Opioid Use and Maternal Nutrition and Health Status" — Emily Hohman, College of Health and Human Development; Sarah Kawasaki, College of Medicine; Tammy Corr, College of Medicine; Jennifer Savage Williams, College of Health and Human Development; and Danielle Symons Downs, College of Health and Human Development.

— "The influence of adolescent social stress on morphine behaviors" — Helen Kamens, College of Health and Human Development; Sonia Cavigelli, College of Health and Human Development; and Patricia Sue Grigson, College of Medicine.

— "An Innovative Approach to Tackle the Opioid Epidemic: Utilizing Twitter Data and Integrating Big Data Analytics and Spatial and Social Network Analyses" — Zhen Lei, College of Earth and Mineral Sciences; Guangqing Chi; College of Agricultural Sciences; Cynthia Chuang, College of Medicine; Glenn Sterner, Penn State Abington; Ashton Verdery, College of the Liberal Arts; and Junjun Yin, Social Science Research Institute.

— "Neural mediators and moderators of mindful yoga practice in opiate-dependent individuals" — Emma Rose, College of Health and Human Development; Diana H. Fishbein, College of Health and Human Development; Robert W. Roeser, College of Health and Human Development; Scott Bunce, College of Medicine; and Sarah Bowen, Pacific University – Oregon.

— "Linking accidental overdoses to medical professionals and pharmacies: A population-based social network analysis"  Glenn Sterner, Penn State Abington; Oren M. Gur, Penn State Abington; and Sabahattin Gokhan Ozden, Penn State Abington.

 "PROSPER PLUS: Combining Effective Prevention Education with Supply Side Interventions to Reduce Opioid Misuse" — Janet Welsh, College of Health and Human Development; Daniel Perkins, College of Agricultural Sciences; Derek Kreager, College of the Liberal Arts; and Glenn Sterner, Penn State Abington.

For more information on seed grant funding and other opportunities available through SSRI, visit the Funding Mechanisms website.